HighVista Strategies »

Calumet shares owned by HighVista Strategies

Quarter-by-quarter ownership of Calumet (CLMT) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Calumet

Tip: Access up to 7 years of quarterly data

All positions including Calumet held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Calumet by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.6M 44k 36.02

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Definium Therapeutics Com Shs (DFTX)
Immunovant (IMVT)
Praxis Precision Medicines I Com New (PRAX)
Relay Therapeutics (RLAY)
Alkermes SHS (ALKS)
Vaxcyte (PCVX)
Tango Therapeutics (TNGX)
Liquidia Corporation Com New (LQDA)
Cogent Biosciences (COGT)
Structure Therapeutics Sponsored Ads (GPCR)
Enliven Therapeutics (ELVN)
Amylyx Pharmaceuticals (AMLX)

View all positions for HighVista Strategies

Top funds holding Calumet

Two Seas Capital
BlackRock
Wasserstein Debt Opportunities Management
Vanguard Capital Management
State Street Corporation
Susquehanna International
Adams Asset Advisors
Geode Capital Management
Citadel Advisors
Graham Capital Management
Barclays
Morgan Stanley
Vanguard Portfolio Management
Bank of America Corporation
Wellington Management Company

View all funds holding Calumet